Record number :
2432372
Title of article :
Low dose aprotinin increases mortality and morbidity in coronary artery bypass surgery
Author/Authors :
Aghadavoudi, Omid Isfahan University of Medical Sciences, Isfahan
Pages :
1
From page :
313
To page :
313
Abstract :
I read with interest the article of Dr Sabzi and colleagues entitled “Low dose aprotinin increases mortality and morbidity in coronary artery bypass surgery” in this journal.[1] In this clinical trial study the authors have enrolled about 650 patients undergoing coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB). Low dose aprotinin (2 million kallikrein inactivation units (KIU) during initiation of CPB) had been given to 273 patients in aprotinin group. The authors have found decreased rate of blood product transfusions but increased rate of morbidity in this group.
Keywords :
Coronary Artery Bypass Graft (CABG) Surgery , Antifibrinolytic Agents , Aprotinin
Journal title :
Astroparticle Physics
Serial Year :
2012
Link To Document :
بازگشت